Pediatric HIV Infection Treatment Demand Driven by Growing Prevalence of Ophthalmic Diseases, Says Fact.MR

Fact.MR, a global research and consulting firm, in the updated edition of the report, opines Pediatric HIV Infection Treatment market to grow at a steady rate in 2021 & beyond. The Growth is primarily propelled by growing prevalence of HIV infection in kids. Active participation of international and national government bodies to support the research on HIV infection treatment drugs is accountable to boost demand amid the forecast period. 

Pediatric HIV infection treatment industry is anticipated to foresee the positive impacts of concentration on early intervention in the form of an efficient measure to avert damage to immune system in addition to delay spreading of infection.” states Fact.MR.

Growing Need for Reducing Mother-to-Child Transmission of HIV will boost demand

The world targets to eliminate mother-to-child HIV transmission, thus eliminating child HIV cases and consequently the requirement for pediatric formulations. Efficient treatments could reduce the threat of HIV transmission from mother-to-child. Conversely, in majority of the resource-limited nations where the instances of HIV is higher, the infection treatment is still not extensively accessible. 

This is boosting the need for research & development activities to cater growing demand for pediatric HIV infection treatment.

Request Sample Report-

Antiretroviral (ARV) drugs will Continue to Support the Growth  

Antiretroviral (ARV) drugs are poised to remain the ancillary to the industry. Globally, every year, around 150,000 over children are infected with HIV infection, with around 110,000 children deaths. This has made adherence to ARV drugs vital to HIV management.

Appropriate adherence to ART prompts lower viral loads, decreased viral resistance and reduced symptoms in patients. Since ARV drugs becomes more compelling, it increases the immunological reaction for HIV-infected children, therefore extending their life prospect.

How Huge is the US Pediatric HIV Infection Treatment Industry?

The US is anticipated to foresee faster revenue advance in contrast with markets in other regions on account of higher infection rate amid children as well as a huge number of pediatric population suffering from HIV infection.

China and India are also the fastest expanding regions in the as a result of higher involvement of non-government and government bodies in endorsing HIV infection treatment campaigns. 

On the other hand, as 90% of children living with HIV exist in sub-Saharan Africa, as well as HIV/AIDS is the prevelant cause of death for adolescents in Africa has fast-tracked the need for infection treatment.

Partnerships for the R&D Activities Remain Key Focus Areas: Fact.MR Survey

With the presence of few significant number of market players Pediatric HIV Infection Treatment market seems to be extremely fragmented. Fact.MR’s survey with thought leaders revealed that market players are focusing on public - private partnerships for the R&D activities in 2021 and beyond. The updated edition of the report provides comprehensive coverage of the projected to remain the key strategies of market players. Some of the players profiled in the report are F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., ViiV Healthcare, Johnson & Johnson Services, Inc., Camber Pharmaceuticals, Inc., and Apotex Inc.. The updated edition also offers a detailed analysis of the COVID-19 impact on this market.

Explore Fact.MR’s Healthcare Reports Delve into Fact.MR’s extensive study on the absorbent dressing market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities. The global large macrolide drugs market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets. Fact.MR’s global wearable cardiac monitors market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Back to news